ArticleAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica2026
Fibrosis in One-Year Protocol Biopsies After Liver Transplantation Is Associated With Graft Loss: A Multicenter Cohort Study.
Article in APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subclinical inflammation and fibrosis are common after liver transplantation and are associated with progressive fibrosis and cirrhosis, which are causes of graft loss. However, the association between early inflammation and fibrosis with graft loss remains insufficiently studied. In this multicenter cohort study, protocol biopsies collected one year posttransplant were assessed for inflammation and fibrosis. Fibrosis risk was assessed in recipients with paired biopsies at 1 year and ≥ 2 years posttransplantation. Associations of inflammation and fibrosis with graft loss and mortality were assessed using Cox regression. Graft loss was defined as re-transplantation or death due to liver complications. We included 446 liver transplant recipients. One year after transplantation, 54 recipients (18%) had inflammation, and 48 (12%) had fibrosis. In multivariable analysis, fibrosis was associated with graft loss, aHR 6.72 (95% CI: 1.36-33.29). In paired biopsies, recipients with fibrosis one year after transplantation had a fivefold higher risk of fibrosis at follow-up than those without. Inflammation was not associated with graft loss or mortality, and fibrosis was not associated with mortality. To conclude, recipients with fibrosis one year after transplantation had an increased risk of graft loss. Protocol biopsies remain valuable for detecting subclinical changes, pending further research to determine the effect on graft loss prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.